Jagadish Gogate
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Schizophrenia research and treatment, Sepsis Diagnosis and Treatment, Immune Response and Inflammation, Treatment of Major Depression
Most-Cited Works
- → Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis(2013)784 cited
- → Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial(2006)749 cited
- → Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*(2009)223 cited
- → A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS(2006)172 cited
- → Response to Higher Doses of Interferon Alfa–2B in Patients With Chronic Hepatitis C: A Randomized Multicenter Trial(1996)118 cited
- → Women's use of information regarding hormone replacement therapy(1990)51 cited
- → Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564) and on Other Therapies for Severe Sepsis(2011)35 cited
- → Capturing and Clustering Women's Judgment Policies: The Case of Hormonal Therapy for Menopause(1991)31 cited
- → Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine(2022)26 cited
- → Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results of a Randomized, Multicenter Trial.(2005)20 cited